Forcing PBMs to reveal hidden compensation to health plan advisors
S. 3349 — PBM Disclosure Act · Filed by Roger Marshall (R-KS) · 1 cosponsor · Introduced Dec 4, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill clarifies that pharmacy benefit managers (PBMs) and third-party administrators must disclose all direct and indirect compensation they receive from employer health plans to the brokers and consultants advising those plans. The bill amends existing ERISA disclosure rules to explicitly name PBM services as a category requiring full compensation transparency, and directs the Department of Labor to issue regulations within 180 days to clarify how this disclosure requirement applies.
Why we flagged it
The bill's operative mechanism is a clarification and expansion of existing ERISA disclosure requirements specifically targeting pharmacy benefit manager compensation. It is a transparency measure designed to expose financial conflicts in health plan administration, not a subsidy, carve-out, or deregulation.
What the text implies
- The bill's framing as a 'clarification' of existing law may face legal challenge from PBMs arguing the amendment imposes a new requirement rather than clarifying an old one; the 'sense of Congress' language in subsection (c) attempts to preempt this but does not bind courts.
- Regulations issued by the Department of Labor will determine the practical scope of 'indirect compensation' — a term not defined in the bill itself. Narrow regulatory interpretation could limit the disclosure requirement's effectiveness.
- The 6-month delayed applicability (regulations apply to plan years beginning 6+ months after promulgation) creates a window during which PBMs may restructure compensation arrangements to avoid disclosure or shift costs to less transparent channels.
- Disclosure to brokers and consultants does not automatically translate to disclosure to plan participants themselves; the bill does not require that information flow downstream to employees and retirees who bear the cost of PBM conflicts.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
Employees and retirees in employer health plans gain transparency into financial conflicts that may affect their plan's drug costs and coverage decisions. PBMs have strong incentives to steer plans toward higher-margin drugs; disclosure of their compensation structures to plan advisors enables better scrutiny of those conflicts and potentially lower out-of-pocket costs for participants.
Named in the bill
Pharmacy Benefit Managers (PBMs), Third-party administrators, Employer-sponsored health plans, Brokers and consultants to health plans, Department of Labor, ERISA (Employee Retirement Income Security Act of 1974), No Surprises Act (Public Law 116–260)
Where it stands
1 cosponsor: 1 Democrats.
- Dec 4, 2025 — Introduced · Congress.gov: “Introduced in Senate”
- Dec 4, 2025 — Referred to Senate Committee on Health, Education, Labor, and Pensions · Congress.gov: “Read twice and referred to the Committee on Health, Education, Labor, and Pensions”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
2 lobbying clients named this bill on 7 disclosure filings across 4 quarters, Dec 2025 to Sep 2026. Those filings disclosed $21,203,034 in lobbying spend. A filing names 37 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 36% of bills with at least one filing.
Roger Marshall, the sponsor, reported $1,921,991 in PAC receipts in the 2026 cycle. $5,000 of that came from 1 PAC tied to these lobbying clients.
- Amgen Inc — $11,720,000 on 4 filings
- Pharmaceutical Care Management Association — $9,483,034 on 3 filings
Lobbying Disclosure Act filings through Oct 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (1,879 characters) on Nov 7, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 17,910 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Dec 2025 to Sep 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Oct 20, 2026 · page rendered 2026-11-22.
“Forcing PBMs to reveal hidden compensation to health plan advisors” QuorumCivic. https://share.quorumcivic.app/bill/119/s3349 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.